戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 2351255作成日:2026年10月27日

1-Heptyne → a-[(tetrahydro-2H-pyran-2-yl)oxy]dec-4-yn-2(R)-ol

https://huagongshe.com/reaction/2351255

反応式

関与物質

役割名称HCID仕込み量
反応物1-HeptyneHCID 12350—
反応物Leukotriene B4HCID 5280492—
反応物(-)-GlycidolHCID 6973630—
反応物L-Ascorbic AcidHCID 54670067—
溶媒Diethyl EtherHCID 3283—
生成物a-[(tetrahydro-2H-pyran-2-yl)oxy]dec-4-yn-2(R)-olHCID 14464847—

反応手順

The starting material for the process of this invention, compound 2, can be prepared as described in Nicolaou, K. C. et al., "A General and Stereocontrolled Total Synthesis of Leukotriene B4 and Analogues," J. Am. Chem. Soc., 106, 3548 (1984) or Hanson, R. M. and Sharpless, K. B., J. Org. Chem., 51 1922 (1986). Briefly, optically active (S)-glycidol THP ether is prepared from ascorbic acid as disclosed in Takano, S., Numata, H., Ogasawara, K., Heterocycles, 19, 237 (1982) and Baldwin, J. J., Raab, A. W., Mensler, K., Arison, B. H., McClure, D. E., J. Org. Chem., 43, 4876 (1978). The ether is reacted (-78°-25° C.) with two equivalents of the anion of 1-heptyne (1.0 equiv. of n-BuLi, 1.0 equiv. of TMEDA and THF, -78° C.) to afford a-[(tetrahydro-2H-pyran-2-yl)oxy]dec-4-yn-2(R)-ol which is then silylated (t-BuPh2SiCl, imidazole, DMF) to, compound 2.

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US04873024
出典データセットuspto-grants-1989_10
ORD IDord-491ea872368f4a6580fbc8c0e583bfc3
出典メモuspto-grants-1989_10